Brief: Ipsen, Skyhawk Therapeutics Announce RNA Targeting Research Collaboration In Rare Neurological Diseases

Ipsen SA

22/04/2024 06:04

April 22 (Reuters) - Ipsen SA  IPN.PA :
    * IPSEN AND SKYHAWK THERAPEUTICS ANNOUNCE RNA TARGETING
RESEARCH
COLLABORATION IN RARE NEUROLOGICAL DISEASES
    * IPSEN SA - UNDER TERMS OF AGREEMENT SKYHAWK IS ELIGIBLE TO
RECEIVE UP TO $1.8 BILLION
    * IPSEN SA - UNDER TERMS OF AGREEMENT SKYHAWK IS ELIGIBLE TO
RECEIVE UP TO $1.8 BILLION
    * IPSEN SA -  WILL ASSUME RESPONSIBILITY FOR FURTHER
DEVELOPMENT
AND COMMERCIALIZATION, LEVERAGING EXISTING NEUROSCIENCE
EXPERTISE IN MOVEMENT DISORDERS
    * IPSEN SA -  WILL ASSUME RESPONSIBILITY FOR FURTHER
DEVELOPMENT
AND COMMERCIALIZATION, LEVERAGING EXISTING NEUROSCIENCE
EXPERTISE IN MOVEMENT DISORDERS
    * IPSEN SA - ENTERS INTO AN OPTION AGREEMENT TO RECEIVE
EXCLUSIVE
GLOBAL RIGHTS TO TWO CANDIDATES PURSUED UNDER COLLABORATION

Source text for Eikon:  ID:nGNE9vQN0k 
Further company coverage:  IPN.PA 

 ((Reuters.briefs@thomsonreuters.com;))